It was announced last year that work at the GlaxoSmithKline plant in Ulverston would cease, which came to pass at the end of June.

Aside from Sandoz' future, Novartis reported a 5% increase in sales of its innovative medicines to $10.7 billion, with group revenues up 4% to $13.2 billion, a little shy of analysts' expectations.

Torrent Pharma makes a bold ₹18,000 crore move to acquire JB Chemicals, signalling a strategic comeback and consolidation ...

A group of Swiss citizens has filed an appeal against plans to install 40 Starlink satellite antennae in the mountain village ...

Compulsory service for all, a tax on million-dollar inheritances, more indirect subsidies for media publishers: the ...

Bunkerspot provides news, in-depth analysis, expert comment and price indications for the global marine fuels industry ...

Novartis started a review of the business in October 2021, after Sandoz had been suffering from pressure on sales and operating profits for several years due mainly to pricing pressures, which ...

Get the latest Sandoz Group AG (SDZNY) stock news and headlines to help you in your trading and investing decisions.

Review the current Sandoz Group AG Registered Shares (SDZ:XSWX) dividend yield and history to decide if SDZ is the best investment for you.

British Royal Family news: Get the latest exclusive British Monarchy features, photos & insider gossip on the UK monarchs from Hello! today ...